Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine

Royal Marsden NHS Foundation Trust

Status: Completed

Conditions: Metastatic Breast Cancer

Treatments: Device: CanADVICE+® (smart phone app)

Study type: Interventional

Funder types: Other

Identifiers

NCT02580396

CCR4404

Details and patient eligibility

About

This feasibility study will be conducted in order to provide proof of concept for the CanADVICE+® system comprising a smart phone app and a healthcare organization server side application based on Web 2 technologies. The main objective of this project is to optimise pharmaceutical counselling services by providing drug related information, in a digital format, to patients with metastatic breast cancer receiving Capecitabine.

Enrollment: 16 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with metastatic breast cancer
• Commencing first cycle of Capecitabine
• Familiar with and own an android smartphone
• Willing to participate

Exclusion criteria

• Patients <18 years
• Patients taking part in any other trial containing Capecitabine
• Chemotherapy-naïve patients

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

16 participants in 1 patient group

Patients eligible for CanADVICE+® (smart phone app)

Other group

Treatment:

Device: CanADVICE+® (smart phone app)